Krystal Biotech logo

Krystal Biotech Share Price (NASDAQ: KRYS)

$147.74

0.86

(0.59%)

Last updated on

Check the interactive Krystal Biotech Stock chart to analyse performance

Krystal Biotech stock performance

as on August 28, 2025 at 1:29 am IST

  • Today's Low:$145.86
    Today's High:$147.74

    Day's Volatility :1.27%

  • 52 Weeks Low:$122.80
    52 Weeks High:$207.84

    52 Weeks Volatility :40.92%

Krystal Biotech Stock Returns

PeriodKrystal Biotech IncSector (Health Care)Index (Russel 2000)
3 Months
17.54%
4.2%
0.0%
6 Months
-14.83%
-8.0%
0.0%
1 Year
-27.6%
-12.0%
0.0%
3 Years
110.07%
7.7%
-6.9%

Krystal Biotech Inc Key Stats

Check Krystal Biotech key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$146.88
Open
$146.92
Today's High
$147.74
Today's Low
$145.86
Market Capitalization
$4.3B
Today's Volume
$174.4K
52 Week High
$207.84
52 Week Low
$122.8
Revenue TTM
$359.2M
EBITDA
$153.2M
Earnings Per Share (EPS)
$4.92
PE Ratio
29.85
Profit Margin
40.85%
Quarterly Earnings Growth YOY
1.43%
Return On Equity TTM
15.61%

Stock Returns calculator for Krystal Biotech Stock including INR - Dollar returns

The Krystal Biotech stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Krystal Biotech investment value today

Current value as on today

₹77,139

Returns

₹22,861

(-22.86%)

Returns from Krystal Biotech Stock

₹27,546 (-27.55%)

Dollar Returns*

₹4,685 (+4.68%)

Indian investors sentiment towards Krystal Biotech Stock

38%

Period: Jul 28, 2025 to Aug 27, 2025. Change in 30 Days versus previous period

Search interest for Krystal Biotech Stock from India on INDmoney has increased by 38% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Krystal Biotech Inc

  • Name

    Holdings %

  • FMR Inc

    14.93%

  • BlackRock Inc

    13.62%

  • Vanguard Group Inc

    9.75%

  • venBio Select Advisor LLC

    9.19%

  • State Street Corp

    4.24%

  • Capital World Investors

    3.26%

Analyst Recommendation on Krystal Biotech Stock

Rating
Trend

Buy

    94%Buy

    5%Hold

    0%Sell

Based on 17 Wall street analysts offering stock ratings for Krystal Biotech(by analysts ranked 0 to 5 stars)

Krystal Biotech Share Price Target

What analysts predicted

Upside of 38.89%

Target:

$205.20

Current:

$147.74

Krystal Biotech share price target is $205.20, a slight Upside of 38.89% compared to current price of $147.74 as per analysts' prediction.

Krystal Biotech Stock Insights

  • Price Movement

    In the last 3 years, KRYS stock has moved up by 109.1%
  • KRYS vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 60.7% return, outperforming this stock by 88.6%
  • KRYS vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 113.9% return, outperforming this stock by 4.8%
  • Price to Sales

    ForKRYS every $1 of sales, investors are willing to pay $11.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.9 for every $1 of sales.

Krystal Biotech Technicals Summary

Sell

Neutral

Buy

Krystal Biotech is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Krystal Biotech Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Krystal Biotech Inc logo
-2.92%
-14.83%
-27.6%
110.07%
208.81%
Regeneron Pharmaceuticals, Inc. logo
5.25%
-16.48%
-51.06%
-0.98%
-5.32%
Beone Medicines Ltd logo
0.7%
7.82%
51.46%
79.4%
24.25%
Vertex Pharmaceuticals Incorporated logo
-17.38%
-18.0%
-20.55%
38.17%
39.4%
Alnylam Pharmaceuticals, Inc. logo
36.48%
91.56%
61.8%
117.28%
242.42%

About Krystal Biotech Inc

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.
Organization
Krystal Biotech
Employees
275
CEO
Mr. Krish S. Krishnan M.B.A., M.S.
Industry
Health Technology

Key Management of Krystal Biotech Inc

NameTitle
Mr. Krish S. Krishnan M.B.A., M.S.
Founder, Chairman, President & CEO
Ms. Suma M. Krishnan
Founder, President of R&D and Director
Ms. Kathryn A. Romano CPA
Executive VP & Chief Accounting Officer
Mr. John Thomas
General Counsel & Corporate Secretary
Mr. John Karakkal
Vice President of North American Sales & Marketing
Ms. Christine Wilson
Head of U.S. Sales & Marketing
Dr. Stephane Paquette Ph.D.
Vice President of Corporate Development
Mr. Josh Suskin
Senior Director & Head of US Human Resources
Mr. Laurent Goux
Senior VP & GM of Europe
Mr. David Chien
Senior Vice President of Clinical Development

Important FAQs about investing in KRYS Stock from India :

What is Krystal Biotech share price today?

Krystal Biotech share price today is $147.74 as on at the close of the market. Krystal Biotech share today touched a day high of $147.74 and a low of $145.86.

What is the 52 week high and 52 week low for Krystal Biotech share?

Krystal Biotech share touched a 52 week high of $207.84 and a 52 week low of $122.80. Krystal Biotech stock price today i.e. is closed at $147.74, lower by 28.92% versus the 52 week high.

How to invest in Krystal Biotech Stock (KRYS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Krystal Biotech on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Krystal Biotech Shares that will get you 0.0102 shares as per Krystal Biotech share price of $147.74 per share as on August 28, 2025 at 1:29 am IST.

What is the minimum amount required to buy Krystal Biotech Stock (KRYS) from India?

Indian investors can start investing in Krystal Biotech (KRYS) shares with as little as ₹87.86 or $1 (as of August 28, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹878.60 in Krystal Biotech stock (as per the Rupee-Dollar exchange rate as on August 28, 2025). Based on Krystal Biotech share’s latest price of $147.74 as on August 28, 2025 at 1:29 am IST, you will get 0.0677 shares of Krystal Biotech. Learn more about fractional shares .

What are the returns that Krystal Biotech has given to Indian investors in the last 5 years?

Krystal Biotech stock has given 208.81% share price returns and 18.89% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?